India — Drugs Technical Advisory Board
Tracked across 6 events · 74 articles · First seen Dec 31, 2025 · Last active Aug 22, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: The India — Drugs Technical Advisory Board is urged by public health experts to maintain over-the-counter access for 2 mg and 4 mg nicotine replacement therapies.
May 07, 2026 · 7 articles
Regulatory
Impact: The India — Drugs Technical Advisory Board was consulted before the ban on high-dose Nimesulide was implemented, indicating its role in drug regulation.
Dec 31, 2025 · 7 articles
Regulatory
On August 22, 2026, the Bangladesh — Ministry of Health and Family Welfare of India issued a notification under Section 26A of the Drugs and Cosmetics Act, 1940, restricting the manufacture, sale, and distribution of…
Impact: The DTAB recommended the restriction based on safety concerns, contributing to the regulatory action. Its recommendations continue to shape drug policy in India.
Aug 21, 2026 · 20 articles
Regulatory
Impact: The India — Drugs Technical Advisory Board is the government's top technical body on drug-related matters that was consulted before the amendment was finalized.
Jun 16, 2026 · 22 articles
Regulatory
Impact: The India — Drugs Technical Advisory Board provided suggestions that formed the basis for the draft notification of the amendments to the Medical Devices Rules, 2017.
Jun 28, 2026 · 6 articles
Regulatory
Impact: The Board was consulted prior to the notification, fulfilling its advisory role under the Drugs and Cosmetics Act.
Jul 08, 2026 · 12 articles
ERGEN INTELLIGENCE
Track India — Drugs Technical Advisory Board live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard